Search research articles
Contact Us
Filters
Showing results (261-270 of 329) with videos related to
Page
of 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Risks of less common cancers in proven mutation carriers with lynch syndrome
Christoph Engel, Markus Loeffler, Verena Steinke, et al.
JAMA Internal Medicine
|
July 19, 2016
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial
Frank Bloos, Evelyn Trips, Axel Nierhaus, et al.
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Blood
|
April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults
Itziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Hemasphere
|
July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
Gerhard Held, Lorenz Thurner, Viola Poeschel, et al.
The Journal of Pathology
|
July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome
Hans Binder, Lydia Hopp, Michal R Schweiger, et al.
Blood Advances
|
February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances
|
December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Age Kos, Evi Regitz, et al.
Acta Neuropathologica
|
March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller, Ruthild G Weber, Edith Willscher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
February 9, 2020
[Socio-demographic and employment-related factors in the German National Cohort (GNC; NAKO Gesundheitsstudie)]
Nico Dragano, Marvin Reuter, Karin Halina Greiser, et al.
Page
of 33
Search research articles
Search
Showing results (261-270 of 329) with videos related to
Sort By:
Page
of 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Risks of less common cancers in proven mutation carriers with lynch syndrome
Christoph Engel, Markus Loeffler, Verena Steinke, et al.
JAMA Internal Medicine
|
July 19, 2016
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial
Frank Bloos, Evelyn Trips, Axel Nierhaus, et al.
Leukemia
|
May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Blood
|
April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults
Itziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Hemasphere
|
July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
Gerhard Held, Lorenz Thurner, Viola Poeschel, et al.
The Journal of Pathology
|
July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome
Hans Binder, Lydia Hopp, Michal R Schweiger, et al.
Blood Advances
|
February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances
|
December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP
Onur Cetin, Igor Age Kos, Evi Regitz, et al.
Acta Neuropathologica
|
March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller, Ruthild G Weber, Edith Willscher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
February 9, 2020
[Socio-demographic and employment-related factors in the German National Cohort (GNC; NAKO Gesundheitsstudie)]
Nico Dragano, Marvin Reuter, Karin Halina Greiser, et al.
Page
of 33